Business Conferences – ACUS, HEB
Source: http://feedproxy.google.com/~r/stockshaven/~3/pejoEJHnbek/Posted on Tuesday, May 12th, 2009 | In Market Commentary, Stocks to Watch
Today I have some exciting news to share with you all. Due to the influx of emails I have been receiving lately on inquiries regarding the latest FDA deadlines on (Public, AMEX:HEB) and (Public, OTC:ACUS), StocksHaven Investments alongside BioMedReports.com will be hosting video and phone conferences with their investor relation spokespersons. Rest assured the conversations will be recorded in real-time with no editing what so ever. I believe this will prove to be a new and ingenious implementation which will in turn help us stand apart from other financial publications.
Here is a copy of the e-mail sent out to HEB’s investor relations on May/12/09:
My name is Michael Vlaicu and I am the founder, and lead investment analyst of a highly successful financial blog and equity advice company. I would like to express my gratitude for your continued support and co-operation on your behalf. As I am a current shareholder and support your ongoing operations, it is in my best interest to give positive feedback to your shareholders on the current and future goals / plans of Hemixpherx Biopharma, Inc. Friday anytime past 3 pm EST would be suitable for me. Would it perhaps be possible to allow the voice conference to be recorded and publicized on my company webpage?
I expect the basis of our discussion will be with regards to the 18.3M at 1.10 PPS offering, although I am also interested in the ongoing pursuit to solidify Ampligen as a viable treatment for Chronic Fatigue Syndrome because there are currently no other FDA approved treatments. Moreover, your partnership with Oragens and the pursuit to develop treatments for HPV, HIV and other globally important viral diseases.
Any developments and insights I may receive will be publicized.
Random Posts
Last 5 posts by Michael Vlaicu
- Technical Breakout Alert Issued for CytRx (NASDAQ:CYTR) - November 23rd, 2009
- Technical Trading Alert for Echo Therapeutics (OTC:ECTE.OB) - November 20th, 2009
- Power3 Investors Looking Forward to Upcoming Expo (OTC:PWRM.OB) - November 18th, 2009
- Bullish Technical Breakout Alert (OTC:SNBP.OB) - November 17th, 2009
- Bullish Technical Breakout Alert (OTC:SNGX.OB) - November 11th, 2009
chronic fatigue syndrome;, Fda, Hemixpherx Biopharma Inc.;, HIV, HPV;, Java, Market Commentary, Michael Vlaicu;, Oragens;, Stocks to Watch, StocksHaven Investments;, treatment for chronic fatigue syndrome;, viral diseases;
 About Michael Vlaicu (http://www.stockshaven.com)
A young and savvy, yet experienced and accomplished investments mogul since ‘01; Michael has amassed a fortune as a private self investor. Recently starting his own successful blog and turning it in to a self-proprietorship — StocksHaven Investments, a company offering advice to thousands of people worldwide and attracting contracts from various reputable sources. The financial news portal can be found at www.StocksHaven.com. Michael has reached Expert Stock Analyst status from a variety of accredited publications. |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.